Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.

Proctor MJ, Talwar D, Balmar SM, O'Reilly DS, Foulis AK, Horgan PG, Morrison DS, McMillan DC.

Br J Cancer. 2010 Sep 7;103(6):870-6. doi: 10.1038/sj.bjc.6605855. Epub 2010 Aug 17.

2.

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.

Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC.

Br J Cancer. 2011 Feb 15;104(4):726-34. doi: 10.1038/sj.bjc.6606087. Epub 2011 Jan 25.

4.

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2011 Nov;47(17):2633-41. doi: 10.1016/j.ejca.2011.03.028. Epub 2011 Jul 1.

PMID:
21724383
5.

Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.

Shafique K, Proctor MJ, McMillan DC, Qureshi K, Leung H, Morrison DS.

Prostate Cancer Prostatic Dis. 2012 Jun;15(2):195-201. doi: 10.1038/pcan.2011.60. Epub 2011 Nov 29.

PMID:
22343838
6.

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.

Verrijken A, Francque S, Mertens I, Talloen M, Peiffer F, Van Gaal L.

Int J Obes (Lond). 2010 May;34(5):899-907. doi: 10.1038/ijo.2010.4. Epub 2010 Feb 9.

PMID:
20142825
7.

The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.

Hefler-Frischmuth K, Seebacher V, Polterauer S, Tempfer C, Reinthaller A, Hefler L.

Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):102-5. doi: 10.1016/j.ejogrb.2009.12.027. Epub 2010 Jan 18.

PMID:
20080329
8.

Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.

Ishizuka M, Nagata H, Takagi K, Kubota K.

Ann Surg. 2009 Aug;250(2):268-72. doi: 10.1097/SLA.0b013e3181b16e24.

PMID:
19638907
9.

Prognostication in advanced cancer: a study examining an inflammation-based score.

Partridge M, Fallon M, Bray C, McMillan D, Brown D, Laird B.

J Pain Symptom Manage. 2012 Aug;44(2):161-7. doi: 10.1016/j.jpainsymman.2011.08.013. Epub 2012 Jun 23.

PMID:
22732417
10.

Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.

Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC.

Cancer. 2013 Jun 15;119(12):2325-32. doi: 10.1002/cncr.28018. Epub 2013 Apr 10.

11.

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.

Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, McMillan DC.

Br J Cancer. 2007 Nov 5;97(9):1266-70. Epub 2007 Oct 9.

12.

Prospective study of the role of inflammation in renal cancer.

Qayyum T, McArdle PA, Lamb GW, Going JJ, Orange C, Seywright M, Horgan PG, Oades G, Aitchison MA, Edwards J.

Urol Int. 2012;88(3):277-81. doi: 10.1159/000334971. Epub 2012 Feb 23.

PMID:
22377628
13.

Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.

Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC.

Am J Surg. 2009 Apr;197(4):544-9. doi: 10.1016/j.amjsurg.2007.12.052. Epub 2008 Jul 9.

PMID:
18614139
14.

The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.

La Torre M, Nigri G, Cavallini M, Mercantini P, Ziparo V, Ramacciato G.

Ann Surg Oncol. 2012 Sep;19(9):2917-23. doi: 10.1245/s10434-012-2348-9. Epub 2012 Apr 10.

PMID:
22488099
15.

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.

Lamb GW, Aitchison M, Ramsey S, Housley SL, McMillan DC.

Br J Cancer. 2012 Jan 17;106(2):279-83. doi: 10.1038/bjc.2011.556. Epub 2011 Dec 13.

16.

Biochemical changes in patients with combined chronic schistosomiasis and viral hepatitis C infections.

Fahim FA, Esmat AY, Hassan GK, Abdel-Bary A.

Dis Markers. 2000;16(3-4):111-8.

17.

Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.

Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY, Cho JY, Kim YR.

Oncology. 2012;83(5):292-9. doi: 10.1159/000342376. Epub 2012 Sep 5.

PMID:
22964877
18.

Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.

Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC.

Ann Surg. 2009 May;249(5):788-93. doi: 10.1097/SLA.0b013e3181a3e738.

PMID:
19387324
19.

Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.

Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Miki C, Kusunoki M.

Oncology. 2013;84(2):100-7. doi: 10.1159/000343822. Epub 2012 Nov 9.

PMID:
23147449
20.

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.

Takeno S, Hashimoto T, Shibata R, Maki K, Shiwaku H, Yamana I, Yamashita R, Yamashita Y.

Oncology. 2014;87(4):205-14. doi: 10.1159/000362601. Epub 2014 Jul 12.

PMID:
25034097

Supplemental Content

Support Center